PHO - Nordic feasibility study
12.10.2018: Nordic feasibility study supports routine patient management using Blue Light Flexible Cystoscopy with Hexvix® in the outpatient setting
Positive results from a feasibility study investigating Hexvix® with flexible cystoscopy in the outpatient (office) setting have been published in Research and Reports in Urology https://bit.ly/2NBgyez . The investigators concluded that routine outpatient management of patients with Blue Light Cystoscopy (BLC™) with a flexible scope for early identification of recurrent lesions using on-site biopsy, is feasible in patients with non-muscle invasive bladder cancer (NMIBC). As a result, small tumors can be managed immediately with fulguration, avoiding the need for referral to the operating room for rigid cystoscopy and TURB under general anesthesia. Logistically, little training appears to be required for urologists and nurses, and, once healthcare professionals become familiar with the procedure, patient flow is smooth. Therefore, BLC with Hexvix using flexible scopes in the outpatient setting offers potential clinical, economic, and patient benefits in the follow-up of patients with NMIBC.
https://photocure.com/news/flex-feasibility-publication/
Improving outpatient bladder cancer follow-up - Video abstract
https://www.youtube.com/watch?v=Trp-43RZEB0
Positive results from a feasibility study investigating Hexvix® with flexible cystoscopy in the outpatient (office) setting have been published in Research and Reports in Urology https://bit.ly/2NBgyez . The investigators concluded that routine outpatient management of patients with Blue Light Cystoscopy (BLC™) with a flexible scope for early identification of recurrent lesions using on-site biopsy, is feasible in patients with non-muscle invasive bladder cancer (NMIBC). As a result, small tumors can be managed immediately with fulguration, avoiding the need for referral to the operating room for rigid cystoscopy and TURB under general anesthesia. Logistically, little training appears to be required for urologists and nurses, and, once healthcare professionals become familiar with the procedure, patient flow is smooth. Therefore, BLC with Hexvix using flexible scopes in the outpatient setting offers potential clinical, economic, and patient benefits in the follow-up of patients with NMIBC.
https://photocure.com/news/flex-feasibility-publication/
Improving outpatient bladder cancer follow-up - Video abstract
https://www.youtube.com/watch?v=Trp-43RZEB0
Redigert 19.01.2021 kl 19:53
Du må logge inn for å svare
Allislost
12.10.2018 kl 14:39
3018
Ingen grunn til at Cysview ikke skal bli mye brukt i outpatient setting altså. Mangler bare mer fokus på First diagnosis nå så blir dette knallbra!
Dyma
17.10.2018 kl 22:52
2761
NSAUA 2018: The Optimal Management of Non-Muscle Invasive Bladder Cancer
https://www.urotoday.com/conference-highlights/aua-2018-northeastern-section/107580-nsaua-2018-the-optimal-management-of-non-muscle-invasive-bladder-cancer.html
https://www.urotoday.com/conference-highlights/aua-2018-northeastern-section/107580-nsaua-2018-the-optimal-management-of-non-muscle-invasive-bladder-cancer.html
Dyma
17.10.2018 kl 22:53
2754
Overcoming Barriers to Progress in Non-muscle Invasive Bladder Cancer - Where Are We In 2018 and Where Will We Be In 5 Years?
https://www.urotoday.com/conference-highlights/global-congress-on-bladder-cancer-2018/106965-overcoming-barriers-to-progress-in-non-muscle-invasive-bladder-cancer-where-are-we-in-2018-and-where-will-we-be-in-5-years.html
https://www.urotoday.com/conference-highlights/global-congress-on-bladder-cancer-2018/106965-overcoming-barriers-to-progress-in-non-muscle-invasive-bladder-cancer-where-are-we-in-2018-and-where-will-we-be-in-5-years.html
Dyma
17.10.2018 kl 22:54
2747
SIU 2018: Transurethral Resection of Bladder Tumors in 2018: Did Urologists Improve It?
https://www.urotoday.com/conference-highlights/siu-2018/107321-siu-2018-transurethral-resection-of-bladder-tumors-in-2018-did-urologists-improve-it.html
https://www.urotoday.com/conference-highlights/siu-2018/107321-siu-2018-transurethral-resection-of-bladder-tumors-in-2018-did-urologists-improve-it.html
Dyma
17.10.2018 kl 22:58
2730
IBCN 2018: Multispectral Imaging Enables Multiparametric Cystoscopy and Transurethral Resection of Bladder Cancer
https://www.urotoday.com/conference-highlights/2018-international-bladder-cancer-network/107549-ibcn-2018-multispectral-imaging-enables-multiparametric-cystoscopy-and-transurethral-resection-of-bladder-cancer.html
https://www.urotoday.com/conference-highlights/2018-international-bladder-cancer-network/107549-ibcn-2018-multispectral-imaging-enables-multiparametric-cystoscopy-and-transurethral-resection-of-bladder-cancer.html
billionæren
18.10.2018 kl 06:22
2559
Det er sjelden man ser bruk av ropetegn i slike artikler, men her klarer de ikke å la være, med god grunn:
Blue light cystoscopy (Cysview) has been extensively studied to investigate improvement in detection of bladder tumors vs. white light cystoscopy. There have been six multi-center phase 3 trials in the US, Canada, and Europe analyzing its role. In a large study by Stenzl A. 5 in patients with Ta or T1 disease, 16% of Ta tumors, 13% of T1 tumors and 46% of carcinoma in-situ (CIS) was diagnosed with the use of blue light cystoscopy only!
Blue light cystoscopy (Cysview) has been extensively studied to investigate improvement in detection of bladder tumors vs. white light cystoscopy. There have been six multi-center phase 3 trials in the US, Canada, and Europe analyzing its role. In a large study by Stenzl A. 5 in patients with Ta or T1 disease, 16% of Ta tumors, 13% of T1 tumors and 46% of carcinoma in-situ (CIS) was diagnosed with the use of blue light cystoscopy only!
Is multi spectral imaging a rival technique?
Dyma
19.10.2018 kl 06:10
2101
18.10.2018: Georgia Urology Physicians Use Innovative Technology to Hunt Down and Treat Bladder Cancers
https://markets.businessinsider.com/news/stocks/georgia-urology-physicians-use-innovative-technology-to-hunt-down-and-treat-bladder-cancers-1027631577
Fra artikkelen:
"Blue Light Cystocopy with Cysview is a game changer," said Dr. Adam Mellis of Georgia Urology. "It is rapidly becoming the standard of care for patients with bladder tumors."
"I am such an advocate for it because it provides so many benefits for my patients," Dr. Mellis explained. "It has the potential to catch cancers that may have been missed otherwise using standard white-light cystoscopy. This, in turn, may lead to better outcomes for patients."
Følgende kan kanskje tolkes som om Georgia Urology har behov for flere blålys enheter fremover...?!?
"Georgia Urology is the largest urology practice in Atlanta and throughout the Southeast. Georgia Urology has more than 30 locations and six ambulatory surgery centers."
https://markets.businessinsider.com/news/stocks/georgia-urology-physicians-use-innovative-technology-to-hunt-down-and-treat-bladder-cancers-1027631577
Fra artikkelen:
"Blue Light Cystocopy with Cysview is a game changer," said Dr. Adam Mellis of Georgia Urology. "It is rapidly becoming the standard of care for patients with bladder tumors."
"I am such an advocate for it because it provides so many benefits for my patients," Dr. Mellis explained. "It has the potential to catch cancers that may have been missed otherwise using standard white-light cystoscopy. This, in turn, may lead to better outcomes for patients."
Følgende kan kanskje tolkes som om Georgia Urology har behov for flere blålys enheter fremover...?!?
"Georgia Urology is the largest urology practice in Atlanta and throughout the Southeast. Georgia Urology has more than 30 locations and six ambulatory surgery centers."
Redigert 19.10.2018 kl 08:30
Du må logge inn for å svare
kreinh
19.10.2018 kl 07:39
2038
Dyma: Knallbra! Dette underbygger veldig tydelig det som selskapet mener med akselererende vekst.
Meget bra, Flexi kommer til og gjøre sus på butikken :)